ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FE02 | BioTech | Panitumumab - 400mg/20ml | 7237/388 | 187460/13 | VECTIBIX | 400mg/20ml | 1 x 20ml | Injectable concentrated solution | Infusion | Mersaco | Amgen Europe BV | The Netherlands | L.L | 2.44 | E2 | Amgen Europe BV | The Netherlands | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FE02 | BioTech | Panitumumab - 400mg/20ml | 7237 | 187460/13 | VECTIBIX | 400mg/20ml | 1 x 20ml | Injectable concentrated solution | Infusion | Mersaco | Amgen Europe BV | The Netherlands | 147,763,999 L.L | 2.44 | E2 | Amgen Europe BV | The Netherlands | 12/12/20 | 0 |